These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27508384)

  • 1. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
    Henderson MC; Hollingsworth AB; Gordon K; Silver M; Mulpuri R; Letsios E; Reese DE
    PLoS One; 2016; 11(8):e0157692. PubMed ID: 27508384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer.
    Qiu C; Wang B; Wang P; Wang X; Ma Y; Dai L; Shi J; Wang K; Sun G; Ye H; Zhang J
    Cancer Sci; 2021 Aug; 112(8):3388-3400. PubMed ID: 34115421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
    Lourenco AP; Benson KL; Henderson MC; Silver M; Letsios E; Tran Q; Gordon KJ; Borman S; Corn C; Mulpuri R; Smith W; Alpers J; Costantini C; Rohatgi N; Yang R; Haythem A; Biren S; Morris M; Kass F; Reese DE
    Clin Breast Cancer; 2017 Nov; 17(7):516-525.e6. PubMed ID: 28624156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
    Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
    Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
    Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
    Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast density does not impact the ability of Videssa® Breast to detect breast cancer in women under age 50.
    Reese DE; Henderson MC; Silver M; Mulpuri R; Letsios E; Tran Q; Wolf JK
    PLoS One; 2017; 12(10):e0186198. PubMed ID: 29069101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
    Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
    Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis.
    Xia J; Shi J; Wang P; Song C; Wang K; Zhang J; Ye H
    Scand J Immunol; 2016 Jun; 83(6):393-408. PubMed ID: 26991924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for and identification of novel tumor-associated autoantigens.
    Conrad K; Bartsch H; Canzler U; Pilarsky C; Grützmann R; Bachmann M
    Methods Mol Biol; 2010; 576():213-30. PubMed ID: 19882265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of an immunodiagnostic model for prediction of breast cancer.
    Qiu C; Wang P; Wang B; Shi J; Wang X; Li T; Qin J; Dai L; Ye H; Zhang J
    Oncoimmunology; 2020; 9(1):1682382. PubMed ID: 32002291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pseudo-targeted metabolomics study based on serum bile acids profiling for the differential diagnosis of benign and malignant breast lesions.
    Luo C; Zhang X; He Y; Chen H; Liu M; Wang H; Tang L; Tu G; Ding M
    Steroids; 2021 Nov; 175():108914. PubMed ID: 34481814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic importance of S100A9 and S100A12 in breast cancer.
    Gunaldi M; Okuturlar Y; Gedikbasi A; Akarsu C; Karabulut M; Kural A
    Biomed Pharmacother; 2015 Dec; 76():52-6. PubMed ID: 26653550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of lung cancer in a real-world cohort
    Liu Z; Zhang F; Jiang J; Zhao C; Zhu L; Liu C; Li N; Qiu L; Shen C; Sheng D; Zeng Q
    Front Oncol; 2023; 13():1166894. PubMed ID: 37081975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies as potential biomarkers for breast cancer.
    Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
    Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and identification of serum protein peak at 6648 m/z as a novel indicator in breast cancer based on mass spectrometry.
    Song D; Yue L; Zhan Y; Zhang J; Yan Z; Fan Y; Yang H; Zhang D; Liu Q; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
    Discov Med; 2017 May; 23(128):283-294. PubMed ID: 28715644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.
    Lacombe J; Mangé A; Bougnoux AC; Prassas I; Solassol J
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1834-42. PubMed ID: 24957886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.
    Anderson KS; Sibani S; Wallstrom G; Qiu J; Mendoza EA; Raphael J; Hainsworth E; Montor WR; Wong J; Park JG; Lokko N; Logvinenko T; Ramachandran N; Godwin AK; Marks J; Engstrom P; Labaer J
    J Proteome Res; 2011 Jan; 10(1):85-96. PubMed ID: 20977275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer.
    Moon PG; Lee JE; Cho YE; Lee SJ; Chae YS; Jung JH; Kim IS; Park HY; Baek MC
    Oncotarget; 2016 Jun; 7(26):40189-40199. PubMed ID: 27250024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.